Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
RVPH
#4846
Reviva Pharmaceuticals Holdings, Inc. Common Stock
0.8
6
USD
-1.15%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
-1.15%
Aylık Değişim
-65.04%
6 aylık değişim
+34.38%
Yıllık Değişim
+10.26%
Önceki Kapanış
0.8
7
Open
0.8
6
Bid
Ask
Low
0.8
6
High
0.8
6
Hacim
3
Piyasalar
ABD Borsası
Sağlık Hizmetleri
RVPH
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
461.59 K
756.66 K
1.02 M
1.4 M
2.34 M
12.81 M
—
Valuation ratios
Enterprise value
71.97 M
14.05 M
62.47 M
124.88 M
71.12 M
57.04 M
141.11 M
Price to earnings ratio
—
—
-3.18
-3.22
-2.01
-1.02
-3.47
Price to sales ratio
—
—
-396.93
-528.26
83.6
227.43
925.82
Price to cash flow ratio
—
—
-4.08
-4.46
-1.79
-0.82
-3.11
Price to book ratio
—
—
6.27
22.1
73.84
2.34
-27.12
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.43
-0.27
-1.29
-1.66
-1.93
-1.25
-1.92
Return on equity %
-0.51
-0.3
-1.98
-6.87
-36.82
-2.3
13.36
Return on invested capital %
-32
-25.89
-3 005.85
-2 076.88
-1 214.46
-1 369.6
-1 432.27
Gross margin %
—
—
100
100
100
100
400
Operating margin %
—
—
12.48 K
16.51 K
-4 291.66
-22.69 K
-58.78 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
12.5 K
16.41 K
-4 169.03
-22.32 K
-58.07 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
8.69
12.66
3.07
1.36
1.01
2.08
4.9
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
-0.01
-0.01
0.04
0.01
0.01
Solvency ratios
Debt to assets ratio
0
—
—
—
—
—
—
Debt to equity ratio
0
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-19.43
-23.8
-20.24
-6.78
-8.52
EBIT per share
—
—
-25.11
-33.4
-18.15
-5.54
-7.18
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
18.98
19.64
8.13
3.98
13.94
Net current asset value per share
—
—
18.98
19.64
8.86
4.16
14.79
Tangible book value per share
—
—
12.62
4.81
0.49
2.38
1.62
Working capital per share
—
—
12.79
5.2
0.05
2.16
0.53
Book value per share
—
—
12.62
4.81
0.49
2.38
1.62
Haberler
Does Cobenfy Have the Potential to Become a Top Drug for BMY?
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.44%
Reviva Pharmaceuticals 10 milyon dolarlık halka arzı 1,50 dolardan fiyatlandırdı
Reviva Pharmaceuticals hisse ve varant arzı açıkladı
D. Boral Capital, Reviva Pharmaceuticals hisse senedi notunu tut olarak düşürdü
D. Boral Capital downgrades Reviva Pharmaceuticals stock rating to hold
Reviva Pharmaceuticals 9 Mart’ta 1’e 20 ters hisse bölümü yapacak
Reviva Pharmaceuticals to implement 1-for-20 reverse stock split on March 9
Vocal biomarker study supports brilaroxazine’s efficacy in schizophrenia
Chardan Capital, Reviva Pharmaceuticals hissesi için alım tavsiyesi ile takibe başladı
Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating
Vanguard Total Stock Market ETF (VTI) Daily Snapshot—12/30/25 - TipRanks.com